Answers are grounded in this paper and cite their sources.
Epigenetic reprogramming regulates post-traumatic brain injury inflammatory responses, serving as both a critical regulatory mechanism and a potential biomarker for assessing neuroinflammatory outcomes. The purpose of this review is to explore the role of epigenetics in regulating neuroinflammation following traumatic brain injury. Epigenetic mechanisms, including DNA methylation, histone modifications, RNA methylation, and non-coding RNA, influence the progression of traumatic brain injury by regulating the expression of inflammation-related genes. Accumulating evidence has shown that key inflammatory pathways play an important role in post-traumatic brain injury neuroinflammation, while epigenetic mechanisms regulate the activity of these pathways. Studies have indicated that DNA methylation influences neuroinflammation by altering gene expression patterns; N6-methyladenosine RNA methylation dynamically regulates the stability of inflammation-related mRNAs; histone deacetylases exacerbate nerve damage by promoting the expression of inflammatory genes. Non-coding RNAs (such as miRNAs, lncRNAs, and circRNAs) further influence the progression of neuroinflammation by regulating the expression of inflammatory factors. Epigenetic therapeutic strategies, such as histone deacetylase inhibitors and non-coding RNA regulation, have shown potential therapeutic effects. However, current epigenetic therapies face challenges such as insufficient specificity, blood-brain barrier limitations, and concerns about long-term safety. Future efforts should focus on overcoming these challenges through precise delivery systems and multi-targeted therapeutic strategies. With the advancement of technology, particularly single-cell multi-omics analysis and engineered nanoparticles, epigenetic therapies hold promise as an effective approach for treating neuroinflammation following traumatic brain injury, providing new insights and a foundation for clinical precision medicine.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: